Cargando…
Leveraging COVID-19 to sustain regulatory flexibility in the treatment of opioid use disorder
The U.S. government declared the opioid epidemic as a national public health emergency in 2017, but regulatory frameworks that govern the treatment of opioid use disorder (OUD) through pharmaceutical interventions have remained inflexible. The emergence of the COVID-19 pandemic has effectively remov...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7900610/ https://www.ncbi.nlm.nih.gov/pubmed/33612196 http://dx.doi.org/10.1016/j.jsat.2020.108263 |